77.6%
anti-PD-1 therapiesNivolumabnon-small-cell lung cancerurothelial bladder cancerrenal cancermelanomaoesophageal cancer
…eatment of melanoma and non-small-cell lung cancer. Since then, anti-PD-1 therapies have revolutionised cancer treatment. The hospital use of nivol…